SCHEMBL26074092

SCHEMBL26074092

Cc1cc(-c2ccc(-c3ccc(N(C)C)cc3)cc2)nc2ccc(F)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 6/20 0.49
▸ TCF4 P15884 1/20 0.49
▸ CTNNB1 P35222 1/20 0.49
▸ KDM1A O60341 2/20 0.48
▸ DHODH Q02127 4/20 0.48
▸ PLA2G2A P14555 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ SYK P43405 1/20 0.42
▸ IDO1 P14902 1/20 0.41
▸ TDO2 P48775 1/20 0.41
▸ IDO2 Q6ZQW0 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075314 0.87 APP (0.43) APPTCF4CTNNB1KDM1ADHODH
SCHEMBL14700162 0.82 DHODH (0.58) DHODHPLA2G2AALDH1A1GAAMEN1
SCHEMBL23590252 0.82 DHODH (0.74) DHODHPLA2G2AALDH1A1GAAMEN1
SCHEMBL10337641 0.81 KDM1A (0.47) APPKDM1AALDH1A1SYKMEN1
SCHEMBL26075568 0.81 APP (0.49) APPDHODHPLA2G2AALDH1A1GAA
SCHEMBL26074120 0.81 PLA2G2A (0.64) DHODHPLA2G2AALDH1A1MEN1KMT2A
SCHEMBL10519962 0.80 KDM1A (0.50) APPKDM1ADHODHALDH1A1SYK
SCHEMBL26074081 0.80 DHODH (0.65) DHODHPLA2G2AALDH1A1MEN1KMT2A
SCHEMBL26074069 0.77 DHODH (0.49) DHODHPLA2G2AALDH1A1GAAMEN1
SCHEMBL26075552 0.77 DHODH (0.51) DHODHPLA2G2AALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD APP 1602/4885TCF4 4528/4885CTNNB1 4157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback